xCures

Precision oncology platform capturing real world evidence, slashing drug development time & saving lives

Image-empty-state_edited.jpg
INVESTMENt

June, 2019

location

Northern California, CA, USA

Sector

Health Tech

co-investors

Vanedge, Metaplanet Holdings

Founder

Mika Newton, CEO

xCures platform transforms complex unstructured medical data directly from the patient’s medical records into structured data suitable for analysis and machine learning. Their A.I. engine then actively cross-references this data against the vast digital library of oncology data to match patients with potential treatments and predict outcomes. This empowers patients and their oncologists to make more informed and effective treatment decisions.